BioPorto Logo

BioPorto

ISIN: DK0011048619 | Ticker: BIOPOR | LEI: 5299004SWFL5JAN4W830
Sector: Health CareSub-Industry: Biotechnology
Country: Denmark

About BioPorto

Company Description

BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers – tools designed to help clinicians make changes in patient management. The Company uses its expertise in antibodies and assay development, as well as its platform for assay development, to create a pipeline of novel and compelling products that focus on conditions where there is a significant unmet medical need, and where the Company’s tests can help improve clinical and economic outcomes for patients, providers, and the healthcare ecosystem.

The Company’s flagship product is The NGAL Test, which has been designed to aid in the risk assessment of Acute Kidney Injury (AKI), a common clinical syndrome that can have severe consequences, including significant morbidity and mortality if not identified and treated early.

Headquarters

Tuborg Havnevej 15, 2900 Hellerup – Denmark

Financial statements

Download as Excel
Line item in (dkk) 01.01.2020 01.10.2020 01.01.2021 01.04.2021 01.07.2021 01.10.2021 01.01.2022 01.04.2022 01.07.2022 01.10.2022 01.01.2023 01.04.2023 01.07.2023
Assets N/A 58,053,000.00 140,286,000.00 121,378,000.00 109,479,000.00 100,691,000.00 81,255,000.00 163,257,000.00 146,878,000.00 133,571,000.00 108,640,000.00 85,295,000.00 112,084,000.00
Noncurrent Assets N/A 16,721,000.00 15,506,000.00 15,182,000.00 14,185,000.00 18,218,000.00 17,058,000.00 16,659,000.00 16,194,000.00 15,667,000.00 7,212,000.00 6,436,000.00 5,832,000.00
Property Plant And Equipment N/A N/A N/A N/A N/A N/A 1,925,000.00 2,161,000.00 1,999,000.00 N/A 1,586,000.00 1,427,000.00 1,245,000.00
Fixtures And Fittings N/A 2,407,000.00 2,448,000.00 2,407,000.00 2,366,000.00 2,109,000.00 1,925,000.00 2,161,000.00 1,999,000.00 1,828,000.00 N/A N/A N/A
Intangible Assets Other Than Goodwill N/A 1,059,000.00 1,152,000.00 1,291,000.00 1,307,000.00 1,179,000.00 1,049,000.00 1,021,000.00 921,000.00 844,000.00 766,000.00 689,000.00 612,000.00
Current Assets N/A 41,332,000.00 124,780,000.00 106,196,000.00 95,294,000.00 82,473,000.00 64,197,000.00 146,598,000.00 130,684,000.00 117,904,000.00 101,428,000.00 78,859,000.00 106,252,000.00
Inventories N/A 3,752,000.00 3,165,000.00 2,629,000.00 3,029,000.00 3,866,000.00 2,718,000.00 2,222,000.00 2,225,000.00 3,202,000.00 2,558,000.00 2,374,000.00 1,755,000.00
Current Trade Receivables N/A 5,693,000.00 6,886,000.00 6,652,000.00 7,346,000.00 7,086,000.00 7,177,000.00 7,305,000.00 8,122,000.00 2,506,000.00 2,829,000.00 4,087,000.00 3,022,000.00
Current Prepayments N/A 958,000.00 930,000.00 1,982,000.00 1,196,000.00 809,000.00 1,769,000.00 1,075,000.00 1,572,000.00 1,018,000.00 1,555,000.00 2,280,000.00 1,939,000.00
Other Current Receivables N/A 2,290,000.00 577,000.00 1,215,000.00 684,000.00 604,000.00 738,000.00 101,440,000.00 1,106,000.00 389,000.00 1,769,000.00 589,000.00 786,000.00
Current Tax Assets Current N/A 4,129,000.00 5,279,000.00 7,003,000.00 8,060,000.00 10,554,000.00 6,272,000.00 7,540,000.00 9,797,000.00 11,843,000.00 6,444,000.00 7,395,000.00 8,968,000.00
Cash and cash equivalents 18,122,000.00 24,510,000.00 107,943,000.00 86,715,000.00 74,979,000.00 59,554,000.00 45,523,000.00 27,016,000.00 107,862,000.00 98,946,000.00 81,792,000.00 57,732,000.00 85,374,000.00
Cash N/A 24,510,000.00 107,943,000.00 86,715,000.00 N/A 59,554,000.00 45,523,000.00 27,016,000.00 N/A N/A N/A N/A N/A
Noncurrent Assets Or Disposal Groups Classified As Held For Sale N/A N/A N/A N/A N/A N/A 0.00 0.00 0.00 N/A 4,481,000.00 4,402,000.00 4,408,000.00
Equity And Liabilities N/A 58,053,000.00 140,286,000.00 121,378,000.00 109,479,000.00 100,691,000.00 81,255,000.00 163,257,000.00 146,878,000.00 133,571,000.00 108,640,000.00 85,295,000.00 112,084,000.00
Equity 25,322,000.00 18,966,000.00 100,912,000.00 86,738,000.00 76,474,000.00 62,821,000.00 45,964,000.00 123,907,000.00 107,917,000.00 91,080,000.00 70,221,000.00 55,213,000.00 81,056,000.00
Issued Capital N/A 199,936,000.00 266,582,000.00 266,582,000.00 267,754,000.00 267,754,000.00 267,754,000.00 334,693,000.00 334,693,000.00 334,693,000.00 334,693,000.00 334,693,000.00 379,670,000.00
Retained Earnings N/A -181,491,000.00 -166,770,000.00 -180,715,000.00 -192,177,000.00 -205,296,000.00 -221,671,000.00 -210,617,000.00 -225,898,000.00 -241,314,000.00 -264,238,000.00 -279,233,000.00 -298,492,000.00
Treasury Shares N/A 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Liabilities N/A 39,087,000.00 39,374,000.00 34,640,000.00 33,005,000.00 37,870,000.00 35,291,000.00 39,350,000.00 38,961,000.00 42,491,000.00 38,419,000.00 30,082,000.00 31,028,000.00
Noncurrent Liabilities N/A 10,275,000.00 8,444,000.00 8,297,000.00 8,044,000.00 11,205,000.00 10,501,000.00 9,720,000.00 9,393,000.00 9,157,000.00 7,448,000.00 6,566,000.00 5,635,000.00
Other Noncurrent Liabilities N/A 1,553,000.00 452,000.00 301,000.00 301,000.00 301,000.00 301,000.00 137,000.00 137,000.00 137,000.00 0.00 0.00 0.00
Current Liabilities N/A 28,812,000.00 30,930,000.00 26,343,000.00 24,961,000.00 26,665,000.00 24,790,000.00 29,630,000.00 29,568,000.00 33,334,000.00 30,971,000.00 23,516,000.00 25,393,000.00
Trade And Other Current Payables To Trade Suppliers N/A 2,204,000.00 4,636,000.00 2,490,000.00 3,584,000.00 5,409,000.00 4,260,000.00 7,233,000.00 6,008,000.00 3,978,000.00 10,457,000.00 5,256,000.00 5,742,000.00
Accruals Classified As Current N/A N/A N/A N/A N/A N/A 17,471,000.00 19,241,000.00 20,327,000.00 N/A 17,237,000.00 15,011,000.00 16,253,000.00
Other Current Payables N/A 23,167,000.00 23,389,000.00 21,346,000.00 19,571,000.00 18,159,000.00 17,471,000.00 19,241,000.00 20,327,000.00 26,004,000.00 N/A N/A N/A
Current Tax Liabilities Current N/A 93,000.00 77,000.00 81,000.00 80,000.00 82,000.00 84,000.00 86,000.00 0.00 97,000.00 80,000.00 78,000.00 78,000.00
Line item in (dkk) 01.01.2020/
01.10.2020
01.01.2020/
01.01.2021
01.07.2020/
01.10.2020
01.01.2021/
01.04.2021
01.01.2021/
01.07.2021
01.01.2021/
01.10.2021
01.01.2021/
01.01.2022
01.04.2021/
01.07.2021
01.07.2021/
01.10.2021
01.10.2021/
01.01.2022
01.01.2022/
01.04.2022
01.01.2022/
01.07.2022
01.01.2022/
01.10.2022
01.01.2022/
01.01.2023
01.04.2022/
01.07.2022
01.07.2022/
01.10.2022
01.10.2022/
01.01.2023
01.01.2023/
01.04.2023
01.01.2023/
01.07.2023
01.04.2023/
01.07.2023
Revenue 15,672,000.00 23,204,000.00 4,742,000.00 5,577,000.00 12,153,000.00 17,447,000.00 24,254,000.00 6,576,000.00 5,294,000.00 N/A 6,502,000.00 15,008,000.00 20,279,000.00 28,969,000.00 8,506,000.00 5,271,000.00 N/A 8,041,000.00 15,789,000.00 7,748,000.00
Profit Loss From Operating Activities -50,757,000.00 -63,590,000.00 -17,705,000.00 -18,178,000.00 -32,694,000.00 -47,170,000.00 -65,255,000.00 -14,516,000.00 -14,476,000.00 N/A -18,218,000.00 -38,355,000.00 -58,324,000.00 -81,527,000.00 -20,137,000.00 -19,969,000.00 N/A -16,950,000.00 -37,805,000.00 -20,855,000.00
Finance Income 4,000.00 4,000.00 0.00 1,334,000.00 922,000.00 1,765,000.00 2,461,000.00 -412,000.00 843,000.00 N/A 185,000.00 1,164,000.00 2,876,000.00 1,185,000.00 979,000.00 1,712,000.00 N/A 22,000.00 57,000.00 35,000.00
Finance Costs 1,512,000.00 3,248,000.00 969,000.00 244,000.00 466,000.00 692,000.00 1,046,000.00 222,000.00 226,000.00 N/A 249,000.00 475,000.00 995,000.00 1,205,000.00 226,000.00 520,000.00 N/A 273,000.00 419,000.00 146,000.00
Profit Loss Before Tax -52,265,000.00 -66,834,000.00 -18,674,000.00 -17,088,000.00 -32,238,000.00 -46,097,000.00 -63,840,000.00 -15,150,000.00 -13,859,000.00 N/A -18,282,000.00 -37,666,000.00 -56,443,000.00 -81,547,000.00 -19,384,000.00 -18,777,000.00 N/A -17,201,000.00 -38,167,000.00 -20,966,000.00
Income Tax Expense Continuing Operations -4,123,000.00 -5,272,000.00 -1,325,000.00 1,724,000.00 -3,251,000.00 -5,726,000.00 -6,727,000.00 -1,527,000.00 -2,475,000.00 N/A 1,252,000.00 -3,545,000.00 -5,445,000.00 -5,624,000.00 -2,293,000.00 -1,900,000.00 N/A -1,141,000.00 -2,458,000.00 -1,317,000.00
Profit (loss) -48,142,000.00 -61,562,000.00 -17,349,000.00 -15,364,000.00 -28,987,000.00 -40,371,000.00 -57,113,000.00 -13,623,000.00 -11,384,000.00 -16,742,000.00 -17,030,000.00 -34,121,000.00 -50,998,000.00 -75,923,000.00 -17,091,000.00 -16,877,000.00 -24,925,000.00 -16,060,000.00 -35,709,000.00 -19,649,000.00
Line item in (dkk) 01.01.2020 01.10.2020 01.01.2021 01.04.2021 01.07.2021 01.10.2021 01.01.2022 01.04.2022 01.07.2022 01.10.2022 01.01.2023 01.04.2023 01.07.2023
Profit (loss) N/A -17,349,000.00 -61,562,000.00 -15,364,000.00 -13,623,000.00 -11,384,000.00 -16,742,000.00 -17,030,000.00 -17,091,000.00 -16,877,000.00 -24,925,000.00 -16,060,000.00 -19,649,000.00
Adjustments For Decrease Increase In Inventories N/A N/A N/A N/A 136,000.00 -701,000.00 616,000.00 496,000.00 493,000.00 -484,000.00 434,000.00 184,000.00 706,000.00
Adjustments For Increase Decrease In Trade Account Payable N/A N/A N/A N/A -1,052,000.00 773,000.00 -376,000.00 1,737,000.00 1,748,000.00 -282,000.00 6,197,000.00 -5,201,000.00 -4,715,000.00
Adjustments For Increase Decrease In Other Operating Payables N/A N/A N/A N/A -3,818,000.00 N/A -5,918,000.00 N/A 2,856,000.00 N/A N/A N/A N/A
Adjustments For Depreciation And Amortisation Expense N/A N/A N/A N/A 2,084,000.00 3,264,000.00 4,329,000.00 1,062,000.00 2,163,000.00 3,270,000.00 3,966,000.00 687,000.00 1,364,000.00
Adjustments For Sharebased Payments N/A 3,299,000.00 5,316,000.00 1,419,000.00 414,000.00 -1,321,000.00 -966,000.00 1,909,000.00 3,802,000.00 5,574,000.00 7,556,000.00 1,065,000.00 1,966,000.00
Other Adjustments For Noncash Items N/A 866,000.00 915,000.00 0.00 284,000.00 0.00 311,000.00 0.00 0.00 0.00 -945,000.00 39,000.00 117,000.00
Cash Flows From Used In Operations N/A -31,945,000.00 -38,353,000.00 -20,827,000.00 -35,479,000.00 -50,491,000.00 -69,030,000.00 -16,427,000.00 -28,409,000.00 -35,942,000.00 -57,768,000.00 -26,077,000.00 -38,892,000.00
Other Inflows Outflows Of Cash Classified As Operating Activities N/A N/A N/A N/A N/A N/A N/A N/A 0.00 N/A 0.00 N/A -1,849,000.00
Cash Flows From Used In Operating Activities N/A -27,506,000.00 -35,616,000.00 -21,069,000.00 -35,120,000.00 -49,850,000.00 -64,577,000.00 -16,625,000.00 -28,742,000.00 -36,111,000.00 -52,485,000.00 -26,328,000.00 -39,254,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 1,046,000.00 1,315,000.00 53,000.00 270,000.00 148,000.00 130,000.00 407,000.00 407,000.00 407,000.00 407,000.00 0.00 0.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 25,000.00 184,000.00 196,000.00 148,000.00 270,000.00 259,000.00 65,000.00 65,000.00 65,000.00 64,000.00 0.00 0.00
Purchase Of Other Longterm Assets Classified As Investing Activities N/A 22,000.00 22,000.00 N/A N/A 23,000.00 N/A N/A N/A N/A N/A N/A N/A
Cash Flows From Used In Investing Activities N/A -1,093,000.00 -1,521,000.00 -249,000.00 -441,000.00 -441,000.00 -412,000.00 -472,000.00 -503,000.00 -503,000.00 -503,000.00 -31,000.00 -31,000.00
Proceeds From Issuing Shares N/A 39,987,000.00 146,620,000.00 N/A N/A 0.00 0.00 N/A N/A N/A N/A N/A N/A
Payments Of Lease Liabilities Classified As Financing Activities N/A 2,101,000.00 2,859,000.00 808,000.00 1,635,000.00 2,368,000.00 3,099,000.00 669,000.00 1,513,000.00 2,773,000.00 3,737,000.00 923,000.00 1,841,000.00
Cash Flows From Used In Financing Activities N/A 35,027,000.00 127,035,000.00 -959,000.00 2,552,000.00 1,819,000.00 1,101,000.00 -1,433,000.00 91,354,000.00 89,783,000.00 88,699,000.00 2,257,000.00 42,729,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 6,428,000.00 89,898,000.00 -22,277,000.00 -33,009,000.00 -48,472,000.00 -63,888,000.00 -18,530,000.00 62,109,000.00 53,169,000.00 35,711,000.00 -24,102,000.00 3,443,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A -40,000.00 -77,000.00 1,049,000.00 45,000.00 83,000.00 1,468,000.00 23,000.00 230,000.00 254,000.00 558,000.00 42,000.00 139,000.00
Cash and cash equivalents 18,122,000.00 24,510,000.00 107,943,000.00 86,715,000.00 74,979,000.00 59,554,000.00 45,523,000.00 27,016,000.00 107,862,000.00 98,946,000.00 81,792,000.00 57,732,000.00 85,374,000.00

Please note that some sums might not add up.

Filings & Publications

2023

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

DK0011048619

LEI

5299004SWFL5JAN4W830

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Nasdaq Copenhagen

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.